Relevium Provides Corporate Update on Its Medical Cannabis Strategy

MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis...

Relevium Announces Private Share Purchase by CEO

MONTREAL, May 21, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that Mr. Aurelio Useche, Chief Executive Officer, has agreed to purchase a total of 4,213,713...